Your SlideShare is downloading. ×
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)

762

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total Views
762
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
23
Comments
0
Likes
0
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Get more info on this report!Advanced Drug Delivery Markets (Liposomes, Polymers andMonoclonal Antibodies)December 1, 2010Drug delivery is evolving at a rapid rate with new drug product formulations beingdiscovered frequently. Advanced drug delivery deals with developing solutions for newentities in therapeutic pharmacology such as protein and peptides and other novelcompounds targeting drugs to specific disease sites including gene therapy. Treatmentsfor chronic conditions and growth in patient-administered drugs are factors leading togreater focus on ease-of-use and convenience.Advanced Drug Delivery Markets (Liposomes, Polymers and Monoclonal Antibodies)details the types of drug delivery systems, technologies and products utilizing advanceddrug delivery systems The report describes the industry, its relationship to varioushealthcare channels, and the trends for the future.The advanced drug delivery market is two-fold. First of all it identifies drug deliverytechnology Secondly, it identifies products in the pharmaceutical arena that utilize thosedrug delivery technologies. Because drug delivery technology is an integral part of salesof pharmaceuticals and drug delivery technology cannot exist without pharmaceuticals,revenues have been reported that include pharmaceutical sales. This report will providemarket data that includes the pharmaceutical revenues of those products that utilizeadvanced drug delivery.In this report, the advanced drug delivery market is divided into three main segmentsand market estimates are provided for indications within each category: Liposome Drug Delivery (by Indication - Fungal Infections Cancer, Others) Polymer Drug Delivery (by Indication - Cancer, Neutropenia, Hepatitis, Contraception, Schizophrenia, Acromegaly and Others) Monoclonal Antibodies Drug Delivery (by Indication - Arthritis, Cancer, Multiple Sclerosis, Macular Degeneration, Respiratory Syncytial Virus, Others)The following types of polymer delivery drugs are segmented within this report. PEGylated Delivery Emulsuion Delivery Injectable Delivery
  • 2. Nanoparticle Delivery OthersA wide range of trends and issues that will impact the advance drug delivery market arediscussed in the report including the current state of biotechnolgy expansion, molecularimprinted polymers, hot-melt extrusion, metallofullerenes, nanotechnologyadvancements and other emerging Drug Delivery technologies not yet on the market.The following companies are profiled in the report: Alkermes, Inc. ALZA Corporation AP Pharma Centocor Ortho Biotech, Inc. Eisai , Inc Elan Corporation, Plc EnColl Corporation, Inc. Enzon Pharmaceuticals, Inc Gilead Sciences, Inc. Nektar Therapeutics PDL BioPharma pSivida Corp SurModics, Inc Tolmar, IncThe research conducted by Kalorama Information included comprehensive research ofprimary and secondary sources such as interviews with company executives, companyliterature, databases, investment reports, and medical and business journals. Newtechnologies, market developments, and research and development trends andexpenditures were identified through patent and data-based searches, as well as viainterviews with key personnel. Person-to-person and telephone interviews were theprimary method of gathering information. E-mail correspondence was also used in theinterview process. Interviews with 24 key industry officials, trade associationspokespersons, consultants, healthcare providers, and government personnel werecompiled to form the primary basis of information - particularly revenue and marketshare data- presented in this report.All market data pertains to the worldwide market at the manufacturers’ level and wasmeasured in U.S. dollars. The base year for data was 2010. Historical data are providedfor 2006 through 2009, with forecast data provided for 2010 through 2014. Compoundannual growth rates (CAGR) are provided for the 2006-2010, 2010-2014 and 2006-2014.CHAPTER ONE: EXECUTIVE SUMMARY
  • 3. Overview Market Drivers Market Size and Growth Market TrendsCHAPTER TWO: INTRODUCTION AND OVERVIEW Introduction Scope and Methodology Reasons for Advanced Drug Delivery Systems Phases of Drug ActionCHAPTER THREE: LIPOSOME DRUG DELIVERY Overview Liposome Targeting Passive Targeting Active Targeting New Developments Market Summary Liposome Market by Indication Liposome Market Competitive AnalysisCHAPTER FOUR: POLYMER DRUG DELIVERY Overview Polymeric Implants Biodegradable Polymers Nano- and Microparticulates Polymer Micelles PEGylation Technology Hydrogel Polymers Colloidal systems PLA, PLG, and PLGA Emulsions Proteinaceous microparticles New Developments Market Summary Market for Polymers by Product Type Polymer Market by Indication Polymer Market Competitive AnalysisCHAPTER FIVE: MONOCLONAL ANTIBODY DRUG DELIVERY Overview
  • 4. New Developments Market Summary Monoclonal Antibody Market by Indication Monoclonal Antibody Market Competitive AnalysisCHAPTER SIX: TRENDS AND TECHNOLOGY DEVELOPMENTS Expansion of Biotechnology Incorporation of Technology Molecular Imprinted Polymers Antibiotic Biodegradable Implants Hot-melt Extrusion Technology Sorbent Technology Gene Therapy Drug Delivery Metallofullerenes Antisense Delivery Systems Nanotechnology advancements Camouflaged Nanoparticles Triggerable Drug Delivery Prodrug Drug Delivery Single Chain Antigen-Binding Protein Technology Heat Shock Protein Technology Other Emerging Drug Delivery TechnologiesCHAPTER SEVEN: MARKET SIZE AND GROWTH Total Market Summary Geographical Market Growth Summary Competitive Growth AnalysisCHAPTER EIGHT: COMPANY PROFILES Alkermes, Inc. ALZA Corporation AP Pharma Centocor Ortho Biotech, Inc. Eisai , Inc Elan Corporation, Plc EnColl Corporation, Inc. Enzon Pharmaceuticals, Inc Gilead Sciences, Inc. Nektar Therapeutics PDL BioPharma pSivida Corp SurModics, Inc Tolmar, Inc
  • 5. Available immediately for Online Download athttp://www.marketresearch.com/product/display.asp?productid=2880493 US: 800.298.5699 UK +44.207.256.3920 Intl: +1.240.747.3093 Fax: 240.747.3004

×